Navigation Links
Abveris and Geneious Biologics Collaborate to Advance Antibody NGS Data Analysis
Date:6/11/2019

With a rapidly growing customer base and a wide range of antibody discovery services, Abveris plans to leverage the Geneious Biologics platform as a premium hub for bioinformatics and computer programming capabilities.

Dr. Colby Souders, Chief Technology Officer at Abveris, says: “The Geneious team has done an excellent job accommodating our specific data, resulting in a streamlined, high-throughput workflow that produces accurate data and operates efficiently without the need to integrate multiple bioinformatics platforms. We look forward to continuously improving the platform and its integration into our workflow to combine sequence analytics with metadata and assay data to accelerate candidate selection.”

The Geneious team worked closely with Abveris to optimize and enhance the handling of their antibody NGS data. Jannick Bendtsen, VP Technology Services at Geneious, says: “Abveris is at the cutting edge of antibody drug discovery; they are pushing the boundaries of science and technology. To have Colby and the team select Geneious Biologics is a great honor and a great compliment. We collaborated to integrate our Single Clone Antibody Annotator Pipeline and it now runs out of the box. It’s all about speed and accuracy in the discovery process.”

About Abveris
Abveris is a premium Boston-area contract research organization specializing in antibody discovery. Abveris partners with large and small biopharmaceutical companies to discover novel therapeutic products and critical reagent antibodies using diverse platforms, including the proprietary DiversimAb™ hyperimmune mouse technology and a variety of humanized mice. Additional information about Abveris is available at http://www.abveris.com.

About Geneious and Biomatters
Biomatters empowers its customers with software that transforms biological data into knowledge and actionable insights across the spectrum of biotechnology research and development, including drug discovery, protein engineering and advanced comparative analysis of DNA, RNA and protein sequences. Geneious solutions are created from a deep understanding of customer experience and turn the difficult into the intuitive and easy. That is why Geneious is trusted by over 4,000 companies, universities and institutes all over the globe. http://www.geneious.com

Read the full story at https://www.prweb.com/releases/abveris_and_geneious_biologics_collaborate_to_advance_antibody_ngs_data_analysis/prweb16370725.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Geneious Supports the Transition from Vector NTI
2. Catalent to Launch OneBio Suite for Integrated Biologics Development, Manufacturing and Supply at BIO International 2019
3. 3Bar Biologics and Pivot Bio Help Farmers Increase Crop Productivity and Decrease Need for Fertilizer
4. Royal Biologics Launches Maxx-Cell, the World's Most Advanced Bone Marrow Aspiration Device
5. Dovel Technologies Awarded Biologics Surveillance IDIQ
6. Genedata Announces Aptevo Therapeutics Deploys Genedata Biologics to Streamline Cancer Immunotherapy R&D
7. AcCELLerated Biologics announces strategic partnership with Exceleron Media.
8. Mosaic Biomedicals se une a Northern Biologics
9. Synthetic Biologics Announces Pricing of Public Offering of Common Stock and Warrants
10. Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025
11. MassBiologics receives orphan drug status from FDA for hepatitis C treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2020)... ... 15, 2020 , ... The National Institutes of Health (NIH) has selected McBee ... Maryland and Tysons Corner, Virginia, to provide patent legal services under two separate ten ... field of chemistry. The firm is one of nine firms in the nation awarded ...
(Date:5/14/2020)... (PRWEB) , ... May 13, 2020 , ... ... launch of Bonlacta™, its latest enzyme for the lactose-free dairy market. This unique ... wide range of lactose-free dairy products at competitive costs across North America. , ...
(Date:5/11/2020)... , ... May 11, 2020 , ... ... monitoring software platform for patients with implanted cardiac devices. The Octagos software allows ... one portal. The software greatly simplifies the management of remote transmissions and at ...
Breaking Biology News(10 mins):
(Date:5/30/2020)... ... 29, 2020 , ... The Conference Forum is pleased to ... to the unique role of the Chief Medical Officer in the biotech industry. ... best practices and career development of CMOs and Heads of R&D from different ...
(Date:5/21/2020)... ... 2020 , ... Threats to intellectual property, political pressure to ... conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a ... pandemic commercially weaker, dealing with delays in new product launches and with fewer ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems, today ... and multi-format collection of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... the new distribution partner for all personal care ingredients in Russia and Belarus. ... DuPont preservative portfolio for personal care. , The GENENCARE®OSMS product line ...
Breaking Biology Technology: